These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 17671110)
21. Can molecular markers predict local, regional and distant metastasis in head and neck cancer? Haffty BG Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904 [No Abstract] [Full Text] [Related]
22. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. De Schutter H; Geeraerts H; Verbeken E; Nuyts S Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529 [TBL] [Abstract][Full Text] [Related]
23. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma. Ferris RL; Grandis JR Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953 [No Abstract] [Full Text] [Related]
24. Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO. Kim MM; Glazer CA; Mambo E; Chatterjee A; Zhao M; Sidransky D; Califano JA Oral Oncol; 2006 Feb; 42(2):201-7. PubMed ID: 16266817 [TBL] [Abstract][Full Text] [Related]
25. Somatic mutations in the D-loop of mitochondrial DNA in head and neck squamous cell carcinoma. Liu SA; Jiang RS; Wang WY; Lin JC Head Neck; 2015 Jun; 37(6):878-83. PubMed ID: 24976238 [TBL] [Abstract][Full Text] [Related]
26. Super competition as a possible mechanism to pioneer precancerous fields. Rhiner C; Moreno E Carcinogenesis; 2009 May; 30(5):723-8. PubMed ID: 19126656 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma. Brieger J; Kastner J; Gosepath J; Mann WJ Cancer Genet Cytogenet; 2006 May; 167(1):26-31. PubMed ID: 16682282 [TBL] [Abstract][Full Text] [Related]
28. Tissue microarray - a high-throughput molecular analysis in head and neck cancer. Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941 [TBL] [Abstract][Full Text] [Related]
29. TP53 mutations in head and neck cancer. Perrone F; Bossi P; Licitra L N Engl J Med; 2008 Mar; 358(11):1194-5; author reply 1195. PubMed ID: 18340660 [No Abstract] [Full Text] [Related]
30. Role of molecular markers and gene profiling in head and neck cancers. Gold KA; Kim ES Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943 [TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles. Westra WH; Sidransky D J Natl Cancer Inst; 1998 Oct; 90(20):1500-1. PubMed ID: 9790536 [No Abstract] [Full Text] [Related]
32. Stem cells in head and neck squamous cell carcinoma. Shakib K; Schrattenholz A; Soskic V Br J Oral Maxillofac Surg; 2011 Oct; 49(7):503-6. PubMed ID: 20832149 [TBL] [Abstract][Full Text] [Related]
33. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer. Mithani SK; Smith IM; Zhou S; Gray A; Koch WM; Maitra A; Califano JA Clin Cancer Res; 2007 Dec; 13(24):7335-40. PubMed ID: 18094415 [TBL] [Abstract][Full Text] [Related]
34. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882 [TBL] [Abstract][Full Text] [Related]
35. Head and neck cancer: reduce and integrate for optimal outcome. Belbin TJ; Bergman A; Brandwein-Gensler M; Chen Q; Childs G; Garg M; Haigentz M; Hogue-Angeletti R; Moadel R; Negassa A; Owen R; Prystowsky MB; Schiff B; Schlecht NF; Shifteh K; Smith RV; Zheng X Cytogenet Genome Res; 2007; 118(2-4):92-109. PubMed ID: 18000360 [No Abstract] [Full Text] [Related]
36. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung. Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981 [TBL] [Abstract][Full Text] [Related]
37. Comment on "the flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma" [Kamal-Eldin Ahmed Abou-Elhamd and Tito Naeem Habib. Oral Oncol 2007;43(4):366-72]. Gandolfo S; Pentenero M; Demurtas A; Navone R Oral Oncol; 2008 Jan; 44(1):100-1; author reply 102. PubMed ID: 17714978 [No Abstract] [Full Text] [Related]
38. The surgical pathology of head and neck cancer. Zarbo RJ; Crissman JD Semin Oncol; 1988 Feb; 15(1):10-9. PubMed ID: 3278387 [No Abstract] [Full Text] [Related]
39. [Genetic mutation in head and neck squamous cell carcinoma]. Shiga K Nihon Jibiinkoka Gakkai Kaiho; 2002 Oct; 105(10):1059-64. PubMed ID: 12549511 [No Abstract] [Full Text] [Related]
40. Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma. Sun W; Zhou S; Chang SS; McFate T; Verma A; Califano JA Clin Cancer Res; 2009 Jan; 15(2):476-84. PubMed ID: 19147752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]